IWWM-10 Session 15: Associated and Secondary Malignancy Risks in WM Patients
The following abstracts represent the presentations given at IWWM-10 (NYC-2018), Session 15: Associated and Secondary Malignancy Risks in WM Patients
Session Chair: Alessandra Tedeschi (Italy)
Are WM patients at higher risk for treatment unrelated cancers? J. Castillo (USA)
Should additional cancer screening measures be adopted for WM patients? S. Kastritis (USA)
Therapy-related myeloid neoplasms: Insights from UK R2W Trial R. Owen (UK)
How important are treatment related secondary malignancies in WM? A. Tedeschi (Italy)